← Eichor
Study identifier: NCT07572370 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Breast Cancer

Condition: Breast Cancer  ·  Sponsor: Royal College of Surgeons, Ireland

PhaseN/A
Planned participants560
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients who were diagnosed with breast cancer and have finished their treatment will be given the opportunity to be part of this study. These patients will have been attending surveillance at the Breast Centre in Beaumont Hospital, Ireland for 2 years prior. These patients, who are doing well after breast cancer treatment, will be given the opportunity to enrol in this study, potentially being discharged from in person surveillance after 2 years, while still attending for their annual mammogram. Investigators intend to find out if a simpler follow-up plan could work just as safely, while also improving the patients quality of life.

This description comes directly from the study's public registry record.

Talk to the study team

Emma Forde, Medical Doctor & Scientist  ·  +353896126509  ·  eforde@rcsi.com

Always discuss trial participation with your own doctor first.

Locations (1)

Beaumont HospitalDublin, IrelandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07572370